FrancophonIA/ELRC3.0 huggingface dataset:
English: Conventional reproductive and developmental toxicity studies are not considered relevant, given the nature and the intended clinical use of the medicinal product.
Slovenian: Zaradi narave in nameravane klinične uporabe zdravila običajne študije vpliva na razmnoževanje in razvojno toksičnost niso relevantne.
English: Each implant contains matrix applied characterised autologous cultured chondrocytes.
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsak vsadek vsebuje na matriks nanesene karakterizirane avtologne gojene hondrocite.
English: If you get any side effects, talk to your doctor, surgeon or physical therapist.
Slovenian: Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom, kirurgom ali fizioterapevtom.
English: The surgeon will organise the date for implantation in consultation with the Marketing Authorisation Holder (MAH) or its local representative.
Slovenian: Kirurg bo določil dan za vsaditev zdravila MACI po dogovoru z imetnikom dovoljenja za promet z zdravilom ali njegovim lokalnim predstavnikom.
English: Clinical pharmacology studies have not been conducted on MACI.
Slovenian: Običajne farmakološke študije za zdravilo MACI niso bile izvedene.
English: At the surgeon's discretion, a few interrupted absorbable sutures may also be used to provide
Slovenian: Za dodatno varnost lahko kirurg po lastni presoji uporabi nekaj prekinjenih razgradljivih šivov.
English: Pharmacotherapeutic group: Other Medicines for Disorders of the Musculo-Skeletal system, ATC code: M09AX02
Slovenian: Farmakoterapevtska skupina: druga zdravila za zdravljenje motenj mišično-skeletnega sistema, oznaka
English: Each implantation matrix consists of characterised autologous chondrocytes on a 14.5 cm² Type I/III collagen membrane, at a density of 500,000 to 1,000,000 cells per cm2, to be trimmed by the surgeon to the size and shape of the defect.
Slovenian: Vsak matriks za implantant sestavljajo karakterizirani avtologni hondrociti na 14,5 cm² kolagenske membrane tipa I/III, z gostoto 500.000 do 1.000.000 celic na cm2, kirurg ga obreže glede na velikost
English: Store below 37°C in the outer carton until ready to use.
Slovenian: Do začetka uporabe shranjujte v zunanji ovojnini pri temperaturi do 37 °C do začetka uporabe.
English: • The importance of explaining to the patients: o The risks asociated with the surgical procedures and MACI o The need for clinical follow-up o The need for rehabilitation following articular cartilage repair
Slovenian: o tveganja, ki so povezana s kirurškimi posegi in zdravilom MACI; o pomen rehabilitacije po popravilu sklepnega hrustanca.
English: The implant is an opaque, off-white membrane, seeded with chondrocytes, supplied in 18 ml of colourless solution in a dish.
Slovenian: Vsadek je neprozorna, belkasta membrana, nacepljena s hondrociti, na voljo v 18-mililitrski
English: If this happens, your surgeon will advise you on the best course of action.
Slovenian: V tem primeru vam bo kirurg svetoval najprimernejši nadaljnji potek.
English: • Clinical follow up details The training materials for healthcare professionals involved in the follow-up of patients treated with MACI shall include the following key messages:
Slovenian: Izobraževalno gradivo za zdravstveno osebje, ki sodeluje pri spremljanju bolnikov, zdravljenih z zdravilom MACI, mora vsebovati naslednja ključna sporočila:
English: • If you get any side effects talk to your doctor, surgeon or physical therapist.
Slovenian: • Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom, kirurgom ali fizioterapevtom.
English: Posology
Slovenian: POSODICA
English: During the first procedure, a sample of healthy cartilage tissue (a biopsy) will be taken from the affected joint by an arthrotomy or arthroscopy.
Slovenian: Med prvim postopkom se odvzame vzorec zdravega hrustančnega tkiva (biopsija) iz prizadetega sklepa v postopku artrotomije ali artroskopije.
English: The MACI implant will be secured in place using a fibrin sealant.
Slovenian: Vsadek zdravila MACI se pritrdi s fibrinskim lepilom.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS DISH
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
English: Even if the surgeon has already taken a small sample of cartilage cells (a biopsy) needed to produce the
Slovenian: Drugi primeri, v katerih zdravila MACI ni mogoče dati Tudi če vam je kirurg že odvzel majhen vzorec hrustančnih celic (biopsijo), potrebnih za izdelavo vsadka zdravila MACI, morda ne boste primerni za zdravljenje z zdravilom MACI.
English: Fibrin sealants containing formaldehyde must not be used with MACI, since formaldehyde is cytotoxic to the chondrocytes.
Slovenian: 4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Z zdravilom MACI se ne sme uporabljati fibrinskih lepil, ki vsebujejo formaldehid, ker je formaldehid
English: Talk to your doctor or surgeon if you are breast-feeding.
Slovenian: Posvetujte se z zdravnikom ali kirurgom, če dojite.
English: CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING
Slovenian: POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Predpisovanje in izdaja zdravila je les posebnim režimom.
English: At the cell processing facility, your cartilage cells will be grown aseptically (free from germs) in culture, to increase the number of cells, and placed onto a sterile collagen membrane to make MACI.
Slovenian: V laboratoriju za obdelavo celic bodo hrustančne celice aseptično (brez klic) razmnožili v mediju, da se poveča število celic, nato pa jih bodo nanesli na sterilno kolagensko membrano, da nastane zdravilo MACI.
English: The administered dose corresponds to 500,000 to 1,000,000 autologous cells/cm of implantation matrix.
Slovenian: Dani odmerek ustreza 500.000 do 1.000.000 avtolognih celic/cm na matriksu za implantacijo.
English: MACI 500,000 - 1,000,000 cells/cm implantation matrix Matrix applied characterised autologous cultured chondrocytes
Slovenian: IME ZDRAVILA MACI 500.000 - 1.000.000 celic/cm matriks za implantacijo na matriks naneseni karakterizirani avtologni gojeni hondrociti
English: Autologous chondrocytes on a 14.5 cm² Type I/III collagen membrane, at a density of between 500,000 and 1,000,000 cells per cm
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN avtologni hondrociti na 14,5 cm² kolagenske membrane tipa I/III, z gostoto 500.000 do 1.000.000 celic
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency: http://www.ema.europa.eu.
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila
English: Risks involved with arthrotomy or arthroscopy or MACI
Slovenian: Tveganja, povezana z artrotomijo, artroskopijo ali zdravilom MACI Vsi kirurški posegi so povezani z določenim tveganjem.
English: At this time MACI will be implanted into the cartilage defect in the affected joint via a second procedure.
Slovenian: Zdravilo MACI se bo vsadilo v okvarjen hrustanec prizadetega sklepa v drugem postopku.
English: At the cell processing facility, the cartilage cells will be grown aseptically in culture to expand the number of cells and placed onto a sterile CE marked porcine derived type I/III collagen membrane, to make MACI.
Slovenian: V laboratoriju za obdelavo celic hrustančne celice aseptično razmnožijo v mediju, da se poveča število celic, nato pa jih nanesejo na sterilno, s CE označeno, iz prašiča pridobljeno kolagensko membrano tipa I/III, da nastane zdravilo MACI.
English: • joint stiffness/numbness
Slovenian: • togost/otrplost sklepa,
English: Oliefabriksvej 45
Slovenian: Genzyme Biosurgery ApS Oliefabriksvej 45
English: At the cell processing facility, the cartilage cells will be grown aseptically in culture to expand the number of cells and placed onto a sterile collagen membrane, to make MACI.
Slovenian: V laboratoriju za obdelavo celic hrustančne celice aseptično razmnožijo v mediju, da se poveča število celic, nato pa se nanesejo na sterilno kolagensko membrano, da nastane zdravilo MACI.
English: MACI 500,000 to 1,000,000 cells/cm implantation matrix
Slovenian: IME ZDRAVILA MACI 500.000 do 1.000.000 celic/cm matriks za implantacijo
English: The MACI will then be implanted into the cartilage defect in your joint by a second procedure.
Slovenian: Nato se v drugem postopku zdravilo MACI vsadi v okvarjen hrustanec v vašem sklepu.
English: MACI will be sent to the treatment facility.
Slovenian: Zdravilo MACI se pošlje v ustanovo, kjer se bolnik zdravi.
English: Denmark
Slovenian: (mediana
English: Rehabilitation
Slovenian: Nosečnost
English: For implantation.
Slovenian: • vročina.
English: The active substance of MACI consists of viable autologous human cartilage cells on a 14.5 cm² Type I/III collagen membrane, at a density of between 0.5 and 1 million cells per cm
Slovenian: Zdravilna učinkovina zdravila MACI je sestavljena iz viabilnih avtolognih humanih hrustančnih celic na 14,5 cm² veliki kolagenski membrani tipa I/III, z gostoto med 0,5 in 1 milijonom celic na cm Druge sestavine zdravila so Eaglov medij, modificiran po Dulbeccu (DMEM) s 4-(2hidroksietil)piperazin-1-etansulfonska kislina natrijem (HEPES).
English: Responded
Slovenian: Dojenje
English: The following information is intended for medical or healthcare professionals only: During the first procedure a sample of healthy cartilage cells (a biopsy) will be taken from the affected joint by an arthrotomy or arthroscopy.
Slovenian: Med prvim postopkom se v postopku artrotomije ali artroskopije odvzame vzorec zdravega hrustančnega tkiva (biopsija) iz prizadetega sklepa.
English: Other medicines and MACI
Slovenian: Vsadek zdravila MACI se pritrdi s
English: Package leaflet: Information for the user MACI 500,000 to 1,000,000 cells/cm2 for implantation
Slovenian: IME ZDRAVILA IN POT(I) UPORABE MACI 500.000-1.000.000 celic/cm matriks za implantacijo
English: • Details of the rehabilitation program
Slovenian: • Podrobnosti kliničnega spremljanja bolnika.
English: • swelling of the joint
Slovenian: • oteklost sklepa,
English: 6.5 Nature and contents of container and special requirement for use, administration or
Slovenian: 6.5 Vrsta ovojnine in vsebina ter posebna oprema za uporabo, dajanje ali implantacijo Zdravilo MACI je poslano v posebej zasnovani sterilni zatesnjeni posodi iz prozornega polistirena.
English: <{MM/YYYY}> <{DD/MM/YYYY}> <{DD month YYYY}>
Slovenian: <{MM/LLLL}> <{DD/MM/LLLL}> <{DD mesec LLLL}>
English: In these cases, the treatment should be immediately withdrawn.
Slovenian: V teh primerih je treba zdravljenje nemudoma ukiniti.
English: 10 DATE OF REVISION OF THE TEXT
Slovenian: 10 DATUM REVIZIJE BESEDILA
English: It is not associated with clinical signs.
Slovenian: Pojav ni povezan s kliničnimi znaki.
English: Each dose of 0.1 g contains:
Slovenian: Vsak odmerek 0,1 g vsebuje:
English: Date of first authorisation: 10/12/2019
Slovenian: Datum pridobitve dovoljenja za promet 10/12/2019:
English: Read carefully the user safety warnings before use.
Slovenian: Pred uporabo natančno preberite varnostna opozorila za uporabnika.
English: Avoid direct contact with the product.
Slovenian: Izogibajte se neposrednemu stiku z zdravilom.
English: In rare occasions, hypersensitivity reactions can occur.
Slovenian: V redkih primerih se lahko pojavijo preobčutljivostne reakcije.
English: The product has an expected positive effect on feed intake by stimulating the appetite but this effect was not measured in the pivotal field trial.
Slovenian: Zdravilo ima pričakovan pozitiven učinek na vnos hrane s spodbujanjem apetita, vendar ta učinek v ključnem terenskem preskušanju ni bil izmerjen.
English: This corresponds to a 3.8 cm line of ointment (see below).
Slovenian: To ustreza 3,8 cm dolgi črti mazila (glejte spodaj).
English: In case of an overdose, symptomatic/supportive treatment should be instituted if needed.
Slovenian: V primeru prevelikega odmerjanja moramo po potrebi uvesti simptomatsko/podporno terapijo.
English: The efficacy of the product was only demonstrated with a 14-day administration corresponding to the current recommendations (see section 4.9).
Slovenian: Učinkovitost zdravila je bila dokazana le za 14-dnevno dajanje, ki ustreza trenutnim priporočilom (glejte poglavje 4.9).
English: In the case of overdose, the same effects as those observed at the recommended therapeutic dose were noted but with a higher incidence.
Slovenian: Pri prevelikem odmerjanju so opazili enake učinke kot pri priporočenem terapevtskem odmerku, vendar z večjo pojavnostjo.
English: Limited data are available on the reproductive toxicity of mirtazapine.
Slovenian: Na voljo je malo podatkov o reproduktivni toksičnosti mirtazapina.
English: The effects of mirtazapine on glucose regulation have not been evaluated.
Slovenian: Učinki mirtazapina na regulacijo glukoze niso bili preučeni.
English: These adverse events, including local reactions, resolved at the end of treatment period with no specific treatment.
Slovenian: Opisani neželeni učinki, vključno z lokalnimi reakcijami, so po koncu obdobja zdravljenja izzveneli brez posebnega zdravljenja.
English: Care should be taken that other animals in the household do not come in contact with the application site until it is dry.
Slovenian: Paziti je treba, da druge živali v gospodinjstvu ne pridejo v stik z mestom nanosa, dokler to ni suho.
English: Alternate the daily application between the left and right ears.
Slovenian: Zdravilo izmenično nanašajte na levi in desni uhelj.
English: Given that pregnant women are considered a more sensitive population, it is recommended that pregnant women or women trying to conceive should avoid handling the product and avoid contact with treated animals throughout the treatment period.
Slovenian: Glede na to, da nosečnice veljajo za občutljivejšo populacijo, je priporočljivo, da se nosečnice in ženske, ki poskušajo zanositi, izogibajo ravnanju z zdravilom in stiku z zdravljenimi živalmi v celotnem obdobju zdravljenja.
English: The efficacy of the veterinary medicinal product has not been established in cats less than 3 years of age.
Slovenian: Učinkovitost zdravila ni bila ugotovljena pri mačkah, mlajših od 3 let.
English: The product can be absorbed via the cutaneous or oral route and can cause drowsiness or sedation.
Slovenian: Zdravilo se lahko absorbira po dermalni ali peroralni poti in lahko povzroči zaspanost ali sedacijo.
English: Do not use in breeding animals (see section 4.3).
Slovenian: Ne uporabite pri vzrejnih živalih (glejte poglavje 4.3).
English: Pharmacotherapeutic Group: Psychoanaleptics, antidepressants ATCvet code: QN06AX11
Slovenian: FARMAKOLOŠKE LASTNOSTI Farmakoterapevtska skupina: Psihoanaleptiki, antidepresivi Oznaka ATC vet: QN06AX11
English: Repetition of the treatment has not been investigated and as such should only be done after benefit-risk balance assessment by the veterinarian.
Slovenian: Ponavljanje zdravljenja ni bilo preučeno, zato se zanj odločamo le na podlagi ocene razmerja korist-tveganje odgovornega veterinarja.
English: In the case of use in cats with diabetes mellitus, glycaemia should be regularly monitored.
Slovenian: V primeru uporabe pri mačkah s sladkorno boleznijo moramo redno spremljati glikemijo.
English: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinarian.
Slovenian: Če opazite kakršne koli stranske učinke, tudi tiste, ki niso navedeni v tem navodilu za uporabo, ali mislite, da zdravilo ni delovalo, obvestite svojega veterinarja.
English: The management of any chronic disease associated with weight loss should include providing appropriate nutrition and monitoring body weight and appetite.
Slovenian: Obvladovanje katere koli kronične bolezni, povezane s hujšanjem, mora vključevati zagotavljanje ustrezne prehrane ter spremljanje telesne mase in apetita.
English: Do not eat, drink or smoke while handling the veterinary medicinal product.
Slovenian: Med ravnanjem z zdravilom ne jejte, pijte ali kadite.
English: The veterinary medicinal product should not be applied on damaged skin.
Slovenian: Tega zdravila ne smemo nanašati na poškodovano kožo.
English: The plasma concentrations of mirtazapine may be also increased when used concomitantly with ketoconazole or cimetidine.
Slovenian: Plazemske koncentracije mirtazapina se lahko zvišajo tudi ob sočasni uporabi ketokonazola ali cimetidina.
English: Do not use in breeding animals.
Slovenian: Ne uporabite pri vzrejnih živalih.
English: Kidney disease may cause reduced clearance of mirtazapine, which may result in higher drug exposure.
Slovenian: Bolezen ledvic lahko povzroči zmanjšan očistek mirtazapina, kar lahko privede do večje izpostavljenosti zdravilu.
English: Non-greasy, homogeneous, white to off-white ointment.
Slovenian: Nemastno, homogeno, belo do umazano belo mazilo.
English: Depending on the severity of vomiting, dehydration or behavioural changes, administration of the product may be discontinued according to the benefit-risk assessment of the veterinarian.
Slovenian: Glede na resnost bruhanja, dehidracije ali vedenjskih sprememb lahko v skladu z oceno razmerja korist-tveganje odgovornega veterinarja, dajanje zdravila ukinemo.
English: The therapy with mirtazapine should not replace necessary diagnostics and/or treatment regimens needed to manage the underlying disease(s) causing unintended weight loss.
Slovenian: Terapija z mirtazapinom ne sme nadomestiti potrebnih diagnostičnih in/ali terapevtskih režimov, potrebnih za obvladovanje osnovnih bolezni, ki so vzrok nenamernega hujšanja.
English: Transdermal use.
Slovenian: Transdermalna uporaba.
English: 80689 Munich
Slovenian: 80689 München
English: It is therefore recommended to treat the animal in the evening.
Slovenian: Zato je priporočljivo, da zdravilo nanesete zvečer.
English: Do not use in animals less than 7.5 months of age or less than 2 kg body weight.
Slovenian: Ne uporabite pri živalih, mlajših od 7,5 meseca, ali tistih, ki tehtajo manj kot 2 kg.
English: Proper diagnosis and treatment of the underlying disease is key to managing weight loss, and treatment options are dependent on the severity of weight loss and underlying disease(s).
Slovenian: Pravilna diagnoza in zdravljenje osnovne bolezni sta ključnega pomena za obvladovanje hujšanja, možnosti zdravljenja pa so odvisne od resnosti izgube telesne mase in osnovne(ih) bolezni.
English: Mirtazapine may increase sedative properties of benzodiazepines and of other substances with sedative properties (antihistamines H1, opiates).
Slovenian: Mirtazapin lahko poveča sedativne lastnosti benzodiazepinov in drugih snovi s sedativnimi lastnostmi (antihistaminiki H1, opiati).
English: Shelf life after first opening the immediate packaging: 30 days.
Slovenian: Rok uporabnosti po prvem odpiranju stične ovojnine: 30 dni.
English: Step 1: Put on impermeable gloves.
Slovenian: 1. korak: Nadenite si neprepustne rokavice.
English: The exact mechanism by which mirtazapine induces weight gain appears to be multifactorial.
Slovenian: Natančen mehanizem, s katerim mirtazapin povzroči povečanje telesne mase, se zdi večfaktorski.
English: Avoid hand to mouth and hand to eye contact until hands have been thoroughly washed.
Slovenian: Preprečite prenos zdravila z rokami v usta in z rokami v oči, dokler si temeljito ne umijete rok.
English: If a dose is missed, apply the veterinary medicinal product the following day and resume daily dosing.
Slovenian: Če odmerek izpustite, zdravilo nanesite naslednji dan in nato nadaljujte dnevno odmerjanje.
English: In these special cases, biochemical hepatic and renal parameters should be regularly monitored during the treatment.
Slovenian: V teh posebnih primerih moramo med zdravljenjem redno spremljati biokemične jetrne in ledvične parametre.
English: The efficacy and safety of the veterinary medicinal product has not been established in cats with severe renal disease and/or neoplasia.
Slovenian: Učinkovitost in varnost zdravila nista bili ugotovljeni pri mačkah s hudo ledvično boleznijo in/ali neoplazijo ledvic.
English: In the case of contact with eyes, rinse the eyes thoroughly with clean water.
Slovenian: V primeru stika z očmi temeljito sperite oči s čisto vodo.
English: The known symptoms of a mirtazapine overdose of > 2.5 mg/kg in cats include: vocalization and behavioural changes, vomiting, ataxia, restlessness, and tremors.
Slovenian: Znani simptomi prevelikega odmerjanja mirtazapina > 2,5 mg/kg pri mačkah so: oglašanje in vedenjske spremembe, bruhanje, ataksija, nemir in tresenje.
English: EU/2/19/247/001
Slovenian: ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/19/247/001
English: The mean AUC0-24 was 100 ng*h/ml (± 51.7).
Slovenian: Povprečna vrednost AUC0-24 je bila 100 ng × h/ml (± 51,7).
English: In the case of hepatic disease, elevated hepatic enzyme levels may be observed.
Slovenian: V primeru bolezni jeter so lahko ravni jetrnih encimov povišane.
English: 27 80689 Munich Germany
Slovenian: 27 80689 München
English: Mirtazapine is an α2-adrenergic receptor antagonist nor-adrenergic and serotonergic antidepressant drug.
Slovenian: Mirtazapin je antagonist adrenergičnih receptorjev α2, noradrenergični in serotoninergični antidepresiv.
English: When used in hypovolemic cats, supportive treatment (fluid therapy) should be implemented.
Slovenian: Pri uporabi pri hipovolemičnih mačkah moramo uvesti podporno zdravljenje (tekočinska terapija).
English: Each plastic bottle with a child resistant cap contains 1 tube (5 g).
Slovenian: Vsaka plastenka z zaporko, varno za otroke, vsebuje 1 tubo (5 g).
English: Do not use during pregnancy and lactation (see section 4.3).
Slovenian: Ne uporabite v obdobju brejosti in laktacije (glejte poglavje 4.3).
English: The median accumulation between first and 35th dose was 3.71X (based on AUC ratio) and 3.90X (based on Cmax ratio).
Slovenian: Mediana akumulacije med prvim in 35. odmerkom je bila 3,71krat (na podlagi razmerja AUC) in 3,90krat (na podlagi razmerja Cmax).
English: This veterinary medicinal product may cause eye and skin irritation.
Slovenian: To zdravilo lahko povzroči draženje oči in kože.
English: Mirtazapine is a potent antagonist of 5-HT2 and 5-HT3 receptors in the central nervous system (CNS), and a potent inhibitor of histamine H1 receptors.
Slovenian: Mirtazapin je močan antagonist receptorjev 5-HT2 in 5-HT3 v centralnem živčnem sistemu (CŽS) in močan zaviralec histaminskih receptorjev H1.
English: The mean terminal half-life of mirtazapine was 19.9 h (± 3.70) and the mean AUC0-24 was 400 ng*h/ml (±100).
Slovenian: Povprečna končna razpolovna doba mirtazapina je bila 19,9 h (± 3,70), srednja vrednost AUC0-24 pa 400 ng × h/ml
English: Treated animals should not be allowed to sleep with owners, especially children and pregnant women during all the period of the treatment.
Slovenian: V celotnem obdobju zdravljenja zdravljene živali ne smejo spati z lastniki, zlasti ne z otroci in nosečnicami.
English: Bioavailability following topical administration was 34% (6.5 to 89%) compared to oral administration during the first 24 hours and 65% (40.1 to 128.0%) based on AUC0-∞.
Slovenian: Biološka uporabnost po lokalnem dajanju je bila 34 % (od 6,5 do 89 %) vrednosti po peroralnem dajanju v prvih 24 urah in 65 % (od 40,1 do 128,0 %)
English: People with known hypersensitivity to mirtazapine should not handle the veterinary medicinal product.
Slovenian: Osebe z znano preobčutljivostjo za mirtazapin ne smejo rokovati s tem zdravilom.
English: The recommended fixed dose has been tested in cats weighing between 2.1 kg and 7.0 kg.
Slovenian: Priporočeni fiksni odmerek je bil testiran na mačkah s telesno maso med 2,1 kg in 7,0 kg.
English: If skin or eye irritation occurs or in case of accidental ingestion, seek immediately medical advice and show the label to the physician.
Slovenian: Če pride do draženja kože ali oči ali v primeru nenamernega zaužitja, se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.